According to multiple meta-analyses, MTHFR C677T and A1298C increase the relative risk for high homocysteine, cardiovascular disease, stroke, neural tube defects, certain pregnancy issues, depression, migraines, and some neuropsychiatric conditions, especially with low folate/B vitamins.[ref] These same variants can lower the risk for certain conditions as well, illustrating tradeoffs of both positive and negative effects
DOI: 10.1038/s41598-020-74022-y PMID: 33046803 View Source Alternative Therapies in Health and Medicine 2025 Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study (n=2, 1020mg IV) Lee E, Walker C, Ayadi B PMID: 40131143 View Source ClinicalTrials.gov 2015 PCO-02 Safety and Pharmacokinetics Trial (Phase 1 Human Study) NCT02637284 View Source For Research Use Only Important Notice This product is sold strictly for research, laboratory, and educational purposes only
Heres a general timeline of what patients might expect: Most patients see the most dramatic changes between months 3 and 6, with benefits continuing to build over time
Furthermore, the GO band gap can be tuned by varying the extent of its oxygen content